Pancreatic Cancer-Related Mutational Burden Is Not Increased in a Patient Cohort With Clinically Severe Chronic Pancreatitis.
Clinical And Translational Gastroenterology
Cowan, Robert W RW; Pratt, Erica D ED; Kang, Jin Muk JM; Zhao, Jun J; Wilhelm, Joshua J JJ; Abdulla, Muhamad M; Qiao, Edmund M EM; Brennan, Luke P LP; Ulintz, Peter J PJ; Bellin, Melena D MD; Rhim, Andrew D AD
Publication Date: 2021-11-18
Variant appearance in text: TP53: 1034A>G; Asn345Ser
appreci8: a pipeline for precise variant calling integrating 8 tools.
Bioinformatics (Oxford, England)
Sandmann, Sarah S; Karimi, Mohsen M; de Graaf, Aniek O AO; Rohde, Christian C; Göllner, Stefanie S; Varghese, Julian J; Ernsting, Jan J; Walldin, Gunilla G; van der Reijden, Bert A BA; Müller-Tidow, Carsten C; Malcovati, Luca L; Hellström-Lindberg, Eva E; Jansen, Joop H JH; Dugas, Martin M
Publication Date: 2018-12-15
Variant appearance in text: TP53: 1034A>G; Asn345Ser
Synergistic activity and heterogeneous acquired resistance of combined MDM2 and MEK inhibition in KRAS mutant cancers.
Oncogene
Hata, A N AN; Rowley, S S; Archibald, H L HL; Gomez-Caraballo, M M; Siddiqui, F M FM; Ji, F F; Jung, J J; Light, M M; Lee, J S JS; Debussche, L L; Sidhu, S S; Sadreyev, R I RI; Watters, J J; Engelman, J A JA
Martelotto, Luciano G LG; Ng, Charlotte Ky CK; De Filippo, Maria R MR; Zhang, Yan Y; Piscuoglio, Salvatore S; Lim, Raymond S RS; Shen, Ronglai R; Norton, Larry L; Reis-Filho, Jorge S JS; Weigelt, Britta B
Noncanonical DNA motifs as transactivation targets by wild type and mutant p53.
Plos Genetics
Jordan, Jennifer J JJ; Menendez, Daniel D; Inga, Alberto A; Noureddine, Maher M; Nourredine, Maher M; Bell, Douglas A DA; Bell, Douglas D; Resnick, Michael A MA